Guidelines and standards for recognizing and diagnosing alpha1-antitrypsin deficiency (AATD) are available to help improve diagnosis rates, enable early-stage intervention and decrease disease progression.1,2
Guidelines and standards for recognizing and diagnosing alpha1-antitrypsin deficiency (AATD) are available to help improve diagnosis rates, enable early-stage intervention and decrease disease progression.1,2